European Journal of Gynaecological Oncology

Print ISSN: 0392-2936 | Online ISSN: 2709-0086

European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.


8th World Congress on Controversies in Breast Cancer (CoBrCa), Edinburgh, Scotland, UK from September 11-13, 2024
32nd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)，Lisbon, Portugal from November 21-23, 2024

Articles

Open Access

Hysteroscopic-view of endometrial atypical hyperplasia. A helpful diagnostic tool in the care and treatment process?

Giancarlo Garuti,Paola Francesca Sagrada,Maurizio Mirra,Ottavia Fornaciari,Giovanna Centinaio,Andrea Finco,Marco Soligo

DOI: 10.22514/ejgo.2024.022

Abstract ( 264 ) PDF (5.44 MB) ( 147 )

Open Access

Impact of diagnostic hysteroscopy on peritoneal washing status and survival rate of patients with endometrial cancer

Cinthia Maciel-Valentín,José Alanis-Fuentes,David Cantú-de-León,Diddier Prada,Jose Carugno,Julio César González-Rodríguez,Salim Abraham Barquet-Muñoz

DOI: 10.22514/ejgo.2024.025

Abstract ( 377 ) PDF (3.56 MB) ( 111 )

Open Access

Necessity of systematic pelvic lymphadenectomy for early-stage cervical cancer

Xinmei Wang,Hongyuan Zhang,Juan Xu,Pengpeng Qu

DOI: 10.22514/ejgo.2024.026

Abstract ( 274 ) PDF (747.99 kB) ( 130 )

Open Access

Is long-term survival possible when conventional cervical cancer treatment options are exhausted?

Olav Tammik,Aavo Lang,Heti Pisarev,Katrin Lang,Karin Tammik

DOI: 10.22514/ejgo.2024.027

Abstract ( 398 ) PDF (2.72 MB) ( 147 )

Open Access

Exploring the impact of surgical interventions and identifying risk factors for recurrence in stage I of borderline ovarian tumors

Seon-Mi Lee,Sanghoon Lee,Jae-Yun Song,Aeran Seol,Hyun-Woong Cho,Kyung-Jin Min,Jin-Hwa Hong,Jae-Kwan Lee,Nak-Woo Lee

DOI: 10.22514/ejgo.2024.030

Abstract ( 393 ) PDF (888.91 kB) ( 150 )

Open Access

A novel pyroptosis-related gene signature for predicting the prognosis of cervical cancer

Dan Li,Zhihua Du,Hualin Song,Rongjuan Li,Changhui Han,Xiao Wang,Ke Wang,Jingtao Luo

DOI: 10.22514/ejgo.2024.031

Abstract ( 363 ) PDF (10.13 MB) ( 108 )

Open Access

Does coexistence of endometrial cancer and adenomyosis affect survival outcomes? A retrospective cohort study

Latife Gözde Buyuksahin,Mujde Can Ibanoglu,Azize Cemre Ozturk,Vakkas Korkmaz,Sadiman Kiykac Altinbas,Yaprak Engin-Ustun

DOI: 10.22514/ejgo.2023.112

Abstract ( 943 ) PDF (321.03 kB) ( 119 )

Open Access

CDCA2 promotes breast cancer progression by downregulating KISS1 expression

Yi Luo,Zeyu Hou,Guoli Feng,Daigang Xiong,Jing Chen

DOI: 10.22514/ejgo.2024.034

Abstract ( 274 ) PDF (3.25 MB) ( 109 )

Open Access

Pure primary ovarian squamous cell carcinoma with homologous recombination deficiency: a case report

Keisuke Ogimoto,Miho Kitai,Takehito Ota,Takaaki Nakanishi,Yukihiro Imai,Toshiko Sakuma,Tamotsu Sudo,Satoshi Yamaguchi

DOI: 10.22514/ejgo.2024.038

Abstract ( 380 ) PDF (24.15 MB) ( 137 )

all

Published Ahead of Print

Open Access

Metabolism related gene signature predicts prognosis and indicates tumor immune infiltration in ovarian cancer

Yaodong Zhang,Xuenan Zhao,Huilan Qiu,Xia Chen,Zhongwei Zhang,Biao Zhu,Liwen Bu,Zuguang Xia

Online publish date: 17 April 2024

DOI: 10.22514/ejgo.2024.040

Abstract ( 235 ) PDF (4 MB) ( 153 )

Open Access

Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia

Hayfa A. AlHefdhi,Asma Saad Habbash,Safar Abadi Al-Saleem,Fatima Riaz,Syed Esam Mahmood,Amal A. AlHefdhi,Saad Abdullah Al Hatim,Abdullah Ali Alqahtani,Naif Shalan Alalyani,Saeed Abdullah Alahmari,Fahad Juwayid Alqahtani,Rawan Hassan Alshehri

Online publish date: 12 January 2024

DOI: 10.22514/ejgo.2024.001

Abstract ( 1171 ) PDF (2.63 MB) ( 139 )

Open Access

Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients

Tianyi Liu,Xinyu Wang,Manyu Li,Tianyu Zhu,Cheng Qiu,Chuhan He,Lanyu Li,Jinfeng Qu

Online publish date: 12 October 2023

DOI: 10.22514/ejgo.2023.073

Abstract ( 1334 ) PDF (25.23 MB) ( 163 )

Open Access

Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature

Yuemei Cheng,Pingyuan Yu,Xiaolei Liang,Yongxiu Yang

Online publish date: 15 September 2023

DOI: 10.22514/ejgo.2023.072

Abstract ( 1185 ) PDF (7.46 MB) ( 167 )

Open Access

Vulvar cancer in young woman—case report

Miloš Pantelić,Branislava Baturan,Marko Stojić,Ljiljana Mladenović-Segedi,Milana Panjković,Anita Krsman

Online publish date: 07 September 2023

DOI: 10.22514/ejgo.2023.070

Abstract ( 1299 ) PDF (1.53 MB) ( 191 )

Open Access

Prognostic value of Ki-67 in patients with ovarian cancer

Su Wan,Chang Su,Yong Wang,Jin Ding,Qingya Jiang,Huafeng Ding,Guantai Ni

Online publish date: 24 July 2023

DOI: 10.22514/ejgo.2023.051

Abstract ( 1416 ) PDF (3.63 MB) ( 193 )

all
Efficacy of sonohysterography and hysteroscopy for evaluation of endometrial lesions in tamoxifen treated patients: a systematic review
Current Update in the Treatment of Cervical Cancer

Special Issues

Special issue title:

Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"

Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors

Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD

Submission deadline: 31 December 2022

Special issue title:

Breast Cancer

Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment

Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD

Submission deadline: 30 April 2022

Special issue title:

Systematic Review or Meta-Analysis in Gynaecological Oncology

Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer

Editor: Enrique Hernandez, MD

Submission deadline: 25 April 2022

Special issue title:

Current Update in the Treatment of Cervical Cancer

Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes

Editor: Carlo Ronsini, MD

Submission deadline: 31 December 2024

Special issue title:

Gynecological Cancer Prevention: A New Prospective

Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology

Editor: Ottavia Dʼoria, MD

Submission deadline: 31 October 2023

Special issue title:

Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods

Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer

Editor: Prof. Takuma Hayashi

Submission deadline: 31 October 2023

Special issue title:

Molecular Characterization in Endometrial Cancer: Progress and Prospects

Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine

Editor: Andrea Giannini, MD, PhD

Submission deadline: 31 December 2022

Special issue title:

Immunotherapy for Gynecological Oncology

Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer

Editor: Tadahiro Shoji, MD

Submission deadline: 31 July 2021

Special issue title:

Enhanced Recovery of Gynecological Oncology

Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management

Editor: Lin Li, MD

Submission deadline: 31 December 2022

Special issue title:

Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy

Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers

Editor: Sharad Ghamande, MD,David Mysona, MD

Submission deadline: 30 March 2022

all

Featured Article

Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181

To Be a Reviewer

If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.

Review for EJGO

Join Editorial Board

You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.

Join Editorial Board

Editor-in-Chief


Prof. Enrique Hernandez, MD, FACOG, FACS.

Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.